MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation

por Zhang, Xin-Yue, Dai, Hai-Ping, Zhang, Ling, Liu, Si-Ning, Dai, Yin, Wu, De-Pei, Tang, Xiao-Wen
Publicado 2021

Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia

por Zhu, Jun-Feng, Dai, Hai-Ping, Zhang, Qian-Qian, Yin, Jia, Li, Zheng, Cui, Qin-Ya, Tian, Xiao-Peng, Liu, Si-Ning, Jin, Zheng-Ming, Zhu, Xia-Ming, Wu, De-Pei, Tang, Xiao-Wen
Publicado 2022

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation

por Shen, Meng-Zhu, Liu, Xin-Xin, Qiu, Zhi-Yuan, Xu, Lan-Ping, Zhang, Xiao-Hui, Wang, Yu, Yan, Chen-Hua, Chen, Huan, Chen, Yu-Hong, Han, Wei, Wang, Feng-Rong, Wang, Jing-Zhi, Liu, Si-Ning, Liu, Kai-Yan, Huang, Xiao-Jun, Mo, Xiao-Dong
Publicado 2022